Category page
Diagnostics companies in Europe — biotech directory
European diagnostics companies span multiple segments: in-vitro diagnostics (IVD) manufacturers regulated under EU IVDR, clinical laboratory networks running patient testing, molecular diagnostic platforms (PCR, sequencing, mass spec), point-of-care device makers, and assay developers. Anchors include Roche Diagnostics (Rotkreuz), Qiagen (Hilden), Siemens Healthineers, Abbott Diagnostics Germany, BioMérieux Italy, plus mid-scale operators like SAGA Diagnostics, Hummingbird Diagnostics, altona Diagnostics, CeGaT, Asper Biogene, E. Gulbis Laboratory. Most carry ISO 13485 certification and CE marking under EU IVDR.
Where does this category cluster most clearly?
Diagnostics is currently most visible through Finland (6), Sweden (5), Lithuania (4), and Estonia (2). Top cities: Espoo, Finland (2), Helsinki, Finland (2), Turku, Finland (2), and Gothenburg, Sweden (1). Most legible records: Scope Fluidics, IDL Diagnostics, Nordic Biomarker, and Elypta.
Which standards and public evidence are already visible?
ISO-13485 (8) and FDA-Inspected (1). Latest review: 22 March 2026. Review cycle: March 2026.
Why this category matters
This page brings companies and infrastructure records into one practical category view so users can compare markets and cities more quickly.
By country
Diagnostics by country
Jump into a country-specific page filtered to this category only.
Ranked list
Top Diagnostics Companies in Europe (2026)
The leading diagnostics and in-vitro diagnostics (IVD) companies in Europe — molecular diagnostics, clinical lab networks, point-of-care, and assay developers — ranked by verified compliance footprint (ISO 13485, IVDR) and disclosure depth.
Explore more
Other categories
Full list
Diagnostics records
23 category records currently match the active filter.
Current review cycle
Scope Fluidics
WarsawPolandDiagnostics
Warsaw diagnostics and microfluidics company developing rapid antimicrobial-resistance and molecular-diagnostics platforms from a Polish innovation base.
- Lead
- Piotr GarsteckiPresident of the Management Board
- Scale
- Diagnostics platform
Current review cycle
IDL Diagnostics
StockholmSwedenDiagnostics
Bromma diagnostics company, formerly AroCell, operating as IDL Diagnostics with a Swedish IVD portfolio spanning oncology and bacteriology testing.
- Lead
- Anders HultmanCEO
- Scale
- Diagnostics platform
Current review cycle
Nordic Biomarker
UmeaSwedenDiagnostics
Umea diagnostics and assay company supplying coagulation and hemostasis reagents, with certified quality systems and Swedish manufacturing-related operating depth.
- Lead
- Rikard RodenCEO
- Scale
- Diagnostics and reagent platform
Current review cycle
Elypta
SolnaSwedenDiagnostics
Solna molecular-diagnostics company developing metabolism-based liquid biopsy tests for earlier cancer detection and recurrence monitoring from the Karolinska campus.
- Lead
- Karl BergmanCEO
- Scale
- Diagnostics development platform
Current review cycle
Biovica
UppsalaSwedenDiagnostics
Uppsala diagnostics company focused on blood-based cancer monitoring and biomarker testing through the DiviTum platform.
- Lead
- Anders RylanderCEO
- Scale
- Commercial diagnostics platform
Current review cycle
Abacus Diagnostica
TurkuFinlandDiagnostics
Turku molecular-diagnostics company developing rapid PCR, sample-to-answer testing, and infectious-disease diagnostic products from Finland.
- Lead
- Petri SalonenCEO
- Scale
- Commercial diagnostics platform
Current review cycle
PentaBase
OdenseDenmarkDiagnostics
Odense molecular-diagnostics and assay company developing qPCR chemistry, oligonucleotide products, and pharmacogenomics-linked testing workflows.
- Lead
- Ole WorsaaeCEO
- Scale
- Specialized diagnostics platform
Current review cycle
Visiopharm
HorsholmDenmarkDiagnostics
Horsholm diagnostics company operating a digital pathology and precision-image-analysis platform for tissue diagnostics and translational research.
- Lead
- Michael GrunkinCEO
- Scale
- Commercial diagnostics platform
Current review cycle
ArcDia International
TurkuFinlandDiagnostics
Turku in-vitro diagnostics company developing automated mariPOC testing systems for infectious-disease diagnostics and near-patient laboratory workflows.
- Lead
- Janne KoskinenCEO and CSO
- Scale
- Commercial diagnostics platform
Current review cycle
Biohit
HelsinkiFinlandDiagnostics
Helsinki diagnostics company focused on gastrointestinal testing, cancer-risk screening support, and laboratory products for clinical use and prevention workflows.
- Lead
- Jussi HahtelaCEO
- Scale
- Commercial diagnostics platform
Current review cycle
Aiforia Technologies
HelsinkiFinlandDiagnostics
Helsinki diagnostics company building AI-assisted pathology software and clinical decision-support workflows for digital histopathology and healthcare research.
- Lead
- Jukka TapaninenCEO
- Scale
- Commercial diagnostics-software platform
Current review cycle
GenEra
RigaLatviaDiagnostics
Riga molecular-genetics laboratory delivering medical DNA testing, NIPT, kinship testing, next-generation sequencing, and specialist genetic diagnostics from Latvia.
- Lead
- Dr. biol. Ilze Radoviča-SpalviņaChairman of the Board
- Scale
- Clinical genetics and molecular-diagnostics platform
Current review cycle
Imunodiagnostika
Vilnius DistrictLithuaniaDiagnostics
Vilnius-district allergy and clinical-immunology diagnostics operator behind the Allergomedica clinic and laboratory platform, focused on modern allergy testing and specialist care.
- Lead
- Tautvydas GylysManager
- Scale
- Clinical allergy and immunology diagnostics platform
Current review cycle
Antegenes
TartuEstoniaDiagnostics
Tartu polygenic-risk and cancer-prevention diagnostics provider combining CE-marked IVD tests, medical-genetics services, and ISO 13485 quality systems from Estonia.
- Lead
- Peeter Padrik, MD, PhDFounder and Chief Executive Officer
- Scale
- Clinical genetics and prevention-diagnostics platform
Current review cycle
Ligence
KaunasLithuaniaDiagnostics
Kaunas echocardiography-analysis and clinical-AI platform delivering MDR-certified heart-ultrasound reporting workflows from Lithuania.
- Lead
- Arnas KaruzasChief Executive Officer
- Scale
- Clinical software platform for echocardiography providers
Current review cycle
Rezus.lt
SiauliaiLithuaniaDiagnostics
Siauliai-headquartered private diagnostics network providing laboratory testing, molecular diagnostics, microbiological diagnostics, and a growing multi-city clinical footprint across Lithuania.
- Lead
- Daiva KazlauskieneFounder and Director
- Scale
- Multi-city private diagnostics network
Current review cycle
Aidian
EspooFinlandDiagnostics
Espoo IVD headquarters developing and manufacturing point-of-care, molecular-diagnostics, microbiology, and hygiene-monitoring products under ISO 13485 and IVDR-aligned quality systems.
- Lead
- Antti KoivulaCEO (interim) and CFO
- Scale
- Global IVD manufacturing and distribution support
Current review cycle
Photocure
OsloNorwayDiagnostics
Oslo bladder-cancer diagnostics headquarters coordinating blue-light cystoscopy commercialization, clinical evidence, and market development.
- Lead
- Dan SchneiderPresident and Chief Executive Officer
- Scale
- Commercial diagnostics operations
Current review cycle
Medix Biochemica
EspooFinlandDiagnostics
Espoo IVD raw-material headquarters and manufacturing base supplying antibodies, antigens, and assay inputs for diagnostic developers.
- Lead
- Steve FergusonChief Executive Officer
- Scale
- Industrial IVD raw-material manufacturing
Current review cycle
QIAGEN
HildenGermanyDiagnostics
German diagnostics and sample-to-insight infrastructure titan centered on molecular testing, sample prep, and bioinformatics workflows in Hilden.
- Lead
- Thierry BernardChief Executive Officer and Managing Director
- Scale
- Global diagnostics manufacturing
Current review cycle
Atrandi Biosciences
VilniusLithuaniaDiagnostics
Vilnius microfluidics company building single-cell analysis instruments, consumables, and workflow systems around its SPC and droplet technology platforms.
- Lead
- Juozas NainysChief Executive Officer and Co-Founder
- Scale
- Micro-scale
Current review cycle
Vitrolife Group
GothenburgSwedenDiagnostics
Gothenburg reproductive-health headquarters and production base combining IVF media, time-lapse imaging, and genomics-linked product operations inside the Vitrolife Group.
- Lead
- Bronwyn BrophyChief Executive Officer
- Scale
- Global Market
Current review cycle
Synlab Estonia
TallinnEstoniaDiagnostics
Tallinn diagnostics network node delivering accredited routine testing, genetics, and high-throughput clinical laboratory services across Estonia.
- Lead
- Rainar AamiseppCEO, Region North & East
- Scale
- Mass Market
FAQ
Frequently asked questions
- What is a diagnostics company?
- Companies developing or manufacturing tests, assays, instruments, reagents, or platforms used to identify disease or biological state. The category includes IVD manufacturers (regulated medical devices), clinical lab networks (running tests), and assay developers (creating new tests). All EU diagnostic products fall under IVDR (in vitro diagnostic regulation, fully applicable since 2022).
- Which European countries lead in diagnostics?
- Switzerland (Roche Diagnostics is the world's largest IVD company). Germany (Qiagen, Siemens Healthineers, altona Diagnostics, CeGaT, Hummingbird Diagnostics, BioSpring). The Nordics with diagnostic platforms. The Baltics have growing molecular diagnostics (Asper Biogene in Estonia, E. Gulbis Laboratory in Latvia, several Lithuanian platforms). Poland adds Diagnostyka S.A., the country's largest clinical lab network.
- What certifications should a diagnostics company hold?
- For IVD products: ISO 13485 (quality management) + CE marking under IVDR. For clinical lab services: country-specific accreditation (e.g. ISO 15189). For molecular tests with regulatory submissions: GLP for any nonclinical safety component. FDA-inspected sites are common among manufacturers selling into the US.
- How are diagnostic companies verified in this directory?
- Every profile is hand-reviewed: leadership confirmed by primary source, physical site address sourced from official disclosures, ISO 13485 / CE / IVDR claims backed by certification documents, and a registry note explaining current operating context.
Next step
Read the category, then move into cities and countries.
Use city pages for local concentration, country pages for market context, and the methodology page when you want to understand how records are reviewed.